Skip to content

Adductor Canal Block: Efficacy in Postoperative Pain Management for Cardiac Surgery

Effectiveness of Adductor Canal Block in Postoperative Co-analgesia for Cardiac Surgery With Saphenous Vein Harvesting

Status
Not yet recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07732465
Acronym
AddEase
Enrollment
120
Registered
2026-07-29
Start date
2026-08-01
Completion date
2027-12-31
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Grafting (CABG) Surgery, Saphenectomy

Keywords

Adductor canal block, Numeric Rating Scale (NRS), Coronary artery bypass grafting (CABG), Saphenectomy, Postoperative period, Placebo-controlled

Brief summary

Adductor Canal Block: Efficacy in Postoperative Pain Management for Cardiac Surgery

Interventions

PROCEDUREAductor canal bloc

Adductor canal bloc with 0,25% bupivacaine + 20 ucg of dexmedetomidine

PROCEDUREControl adductor canal block

Needle insertion mimicking the ACB procedure with injection of a saline solution

Sponsors

Montreal Heart Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* Planned CABG with unilateral or bilateral great saphenous vein (GSV) harvesting, without concomitant valve surgery * Age ≥ 18 years * Ability to understand the protocol and provide written informed consent * ASA physical status I-IV

Exclusion criteria

* Refusal to participate in the study or inability to provide written informed consent * Contraindication to adductor canal block (e.g., local infection, allergy to local anesthetics) * Pre-existing chronic pain associated with chronic use of analgesic medications other than acetaminophen * Pre-existing peripheral neuropathy affecting the leg * Participation in two other interventional studies at the Montreal Heart Institute * Endoscopic vein harvesting performed by the surgical team instead of open saphenectomy technique

Design outcomes

Primary

MeasureTime frameDescription
Leg Pain at RestNumeric rating scale (NRS 0-10) will be performed at 3 hours, 6 hours, 12 hours, and 24 hours after the block injection.The primary outcome will be leg pain at rest, measured using a numeric rating scale (NRS 0-10) at 3 hours, 6 hours, 12 hours, and 24 hours after the block injection. The NRS (Numeric Rating Scale) is a validated and widely used tool for assessing pain intensity in adults, particularly in postoperative and critical care settings. It allows for a simple, reproducible, and easily administered measurement, including during repeated assessments at the patient's bedside. The NRS scale consists of asking the patient to rate their pain on a numeric scale from 0 to 10, where: 0 corresponds to no pain at all 10 corresponds to the worst pain imaginable

Secondary

MeasureTime frameDescription
Total opioid consumptionThe first 48 postoperative hours after procedureCumulative amount administered, expressed in morphine milligram equivalents (MME), during the first 48 postoperative hours (conversion factors used: hydromorphone 1 mg = morphine 5 mg; fentanyl 100 µg = morphine 10 mg).
Postoperative pain unrelated to the saphenous territoryNumeric rating scale (NRS 0-10) performed at 3 hours, 6 hours, 12 hours, and 24 hours after the block injection.Incidence and characterization of postoperative pain unrelated to the saphenous territory (e.g., thoracic or musculoskeletal pain), assessed at the same time points as saphenous pain using a numeric rating scale (NRS 0-10). The NRS (Numeric Rating Scale) is a validated and widely used tool for assessing pain intensity in adults, particularly in postoperative and critical care settings. It allows for a simple, reproducible, and easily administered measurement, including during repeated assessments at the patient's bedside. The NRS scale consists of asking the patient to rate their pain on a numeric scale from 0 to 10, where: 0 corresponds to no pain at all 10 corresponds to the worst pain imaginable
Persistent Postoperative PainAt 3 and 6 months postoperatively, assessed using the NRS.Proportion of patients reporting pain ≥4/10 at the harvest site at 3 and 6 months postoperatively, assessed using the NRS. The NRS (Numeric Rating Scale) is a validated and widely used tool for assessing pain intensity in adults, particularly in postoperative and critical care settings. It allows for a simple, reproducible, and easily administered measurement, including during repeated assessments at the patient's bedside. The NRS scale consists of asking the patient to rate their pain on a numeric scale from 0 to 10, where: 0 corresponds to no pain at all 10 corresponds to the worst pain imaginable
Overall persistent postoperative painAt 3 and 6 months postoperatively.Proportion of patients reporting pain ≥4/10 (all sites combined) at 3 and 6 months postoperatively. The NRS (Numeric Rating Scale) is a validated and widely used tool for assessing pain intensity in adults, particularly in postoperative and critical care settings. It allows for a simple, reproducible, and easily administered measurement, including during repeated assessments at the patient's bedside. The NRS scale consists of asking the patient to rate their pain on a numeric scale from 0 to 10, where: 0 corresponds to no pain at all 10 corresponds to the worst pain imaginable
Presence of hypoesthesiaNumeric rating scale at 3 and 6 months.Presence of hypoesthesia (non-painful) at the saphenectomy site at 3 and 6 months using a numeric rating scale (NRS 0-10). The NRS (Numeric Rating Scale) is a validated and widely used tool for assessing pain intensity in adults, particularly in postoperative and critical care settings. It allows for a simple, reproducible, and easily administered measurement, including during repeated assessments at the patient's bedside. The NRS scale consists of asking the patient to rate their pain on a numeric scale from 0 to 10, where: 0 corresponds to no pain at all 10 corresponds to the worst pain imaginable
Neuropathic characterizationAt 48 hours, 3 months, and 6 months.Quantification of the modified DN4 score at the harvest site at 48 hours, 3 months, and 6 months. Modified DN4 ≥ 3/8: high probability of neuropathic pain Modified DN4 \< 3/8: neuropathic pain unlikely
Block safetyAssessed daily during hospitalization until patient is discharge from the hospital (an average of 7 days), up to 60 days.Number of adverse events related to the adductor canal block observed during the hospital stay, including hematoma, infection, nerve injury, cardiovascular complications, motor block, and signs of local anesthetic systemic toxicity.
Opioid-related side effectsEach time the patient takes opioids during in the postoperative period until discharge from the hospital (an average of 7 days), up to 60 days.Incidence of common opioid-related side effects in each group, including nausea, vomiting, and constipation.
Time to extubationAt extubationTime to extubation after adductor canal block

Countries

Canada

Contacts

CONTACTChristian Ayoub, MD
ayoub_christian@hotmail.com5147088999

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026